You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

  • Technology appraisal guidance
  • Reference number: TA210
  • Published:  15 December 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Vascular disease - clopidogrel and dipyridamole (review): consultee and commentator comments on the ACD

  • Vascular disease - clopidogrel and dipyridamole (review): manufacturer

  • Vascular disease - clopidogrel and dipyridamole (review): professional and patient groups

  • Vascular disease - clopidogrel and dipyridamole (review): other


This page was last updated: 20 October 2010

Back to top